蛋白酶体抑制剂PS-341对U266细胞凋亡和多种细胞因子表达影响的研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省卫生厅基金(H200313);南京医科大学科技发展基金(NY01-62);江苏省中医药管理局基金(158wA0305);江苏省2005年第二批省级产业技术研究与开发项目(20051125)


Study on the effects of proteasome inhibitor PS-341 on apoptosis and expression of cytokines of U266 cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨蛋白酶体抑制剂PS-341(bortezomib)诱导多发性骨髓瘤细胞株U266细胞凋亡时对IL-6、IL-1β和SCF细胞因子表达的影响。方法:用含15%FBS的RPMI1640培养液体外培养U266细胞,分别用0、50、100、150、200 nmol/L的PS-341干预U266细胞4 h后收集,荧光显微镜观察细胞凋亡,Annexin V-FITC/PI双染法流式细胞术(FCM)检测细胞凋亡率的变化,反转录聚合酶链反应(RT-PCR)分析U266细胞IL-6、IL-1β和SCF三种细胞因子表达的改变。结果:荧光显微镜和FCM发现PS-341以浓度依赖方式诱导U266细胞凋亡;PS-341明显抑制U266细胞IL-6、IL-1β和SCF的表达(P < 0.05);对IL-6和SCF的抑制与PS-341浓度成正相关,对IL-1β的抑制在PS-341浓度为0~150 nmol/L时成正比关系,当浓度大于150 nmol/L时差异无显著性。结论:蛋白酶体抑制剂PS-341诱导U266 细胞凋亡时明显抑制其IL-6、IL-1β和SCF的表达,是有效治疗MM的机制之一。

    Abstract:

    Objective:To investigate the effects of proteasome inhibitor PS-341(Bortezomib) on the expression of interleukin-6(IL-6),interleukin-1β(IL-1β) and stem cell factor(SCF) and the apoptosis of U266 cells. Methods:U266 Cells were incubated with RPMI1640 and exposed to 0,50,100,150,200 nmol/L of PS-341 for 4 h, respectively. Then the apoptosis of cells was analyzed by fluorescence microscope and flow cytometry(FCM) with Annexin V-FITC/PI double staining, and the expression of IL-6,IL-1β and SCF was detected by RT-PCR. Results:Fluorescence microscope and FCM showed that PS-341 induced U266 cells apoptosis in a dose-dependent manner; The expression of IL-6, IL-1β and SCF was decreased significantly after PS-341 treatment. The inhibitory effect on IL-6 and SCF was positively related with drug concentration. The expression of IL-1β was decreased gradually when the drug concentration was increased from 0 nmol/L to 150 nmol/L, whereas the expression level of IL-1β remained unchangeable when the drug concentration exceeded 150 nmol/L. Conclusion:Proteasome inhibitor PS-341 could significantly downregulate the expressions of IL-6,IL-1β and SCF in U266 cells, which might be one of the mechanisms for PS-341 for treatment of multiple myeloma.

    参考文献
    相似文献
    引证文献
引用本文

林如峰,陆 化,刘 澎,王永韧,沈文怡,费小明,葛 峥,汪承亚.蛋白酶体抑制剂PS-341对U266细胞凋亡和多种细胞因子表达影响的研究[J].南京医科大学学报(自然科学版),2007,(3):220-223

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2006-09-24
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明